By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Targacept, Inc. 

200 East First Street
Suite 300
Winston-Salem  North Carolina  27101-4165  U.S.A.
Phone: 336-480-2100 Fax: 336-480-2107


SEARCH JOBS
Targacept, Inc. is developing a diverse pipeline of innovative NNR Therapeutics™ for difficult-to-treat diseases and disorders of the nervous system. NNR Therapeutics selectively modulate the activity of specific neuronal nicotinic receptors, a unique class of proteins that regulate vital biological functions that are impaired in various disease states. Targacept's lead program, TC-5214, is being co-developed with AstraZeneca and is in Phase 3 clinical trials as an adjunct treatment for major depressive disorder. Targacept leverages its scientific leadership and proprietary drug discovery platform Pentad™ to generate novel small molecule product candidates to fuel its pipeline and attract significant collaborations with global pharmaceutical companies.

Targacept’s news releases are available on its website at www.targacept.com.


Key Statistics


Email: heather.savelle@targacept.com
Ownership: Public

Web Site: Targacept
Employees: 120
Symbol: TRGT
 









Company News
Catalyst Biosciences Completes Merger With Targacept (TRGT) And Creates A Protease-Based Hemostasis And Anti-Complement Company 8/21/2015 7:30:06 AM
Targacept (TRGT) Announces Stockholder Approval Of Proposals Related To Merger With Catalyst Biosciences 8/19/2015 11:17:25 AM
Targacept (TRGT) Declares Pre-closing Dividend In Connection With Its Merger With Catalyst Biosciences 8/5/2015 10:57:18 AM
Targacept (TRGT) And Catalyst Biosciences Amend Definitive Merger Agreement 5/14/2015 8:35:23 AM
Targacept (TRGT) Winces As Last Remaining Drug Candidate Flops in Phase II Trial 4/16/2015 11:43:15 AM
Targacept (TRGT) Announces Negative Top-Line Results From Exploratory Study Of TC-6499 In Diabetic Gastroparesis 4/16/2015 10:57:09 AM
Targacept (TRGT) Abandons Nictoine Focus for Alzheimer's 4/6/2015 5:43:27 AM
Bay Area's Catalyst Biosciences to Merge With Unlucky Targacept (TRGT) 3/6/2015 6:36:53 AM
Targacept, Inc. (TRGT) Reports Third Quarter 2014 Financial Results 11/5/2014 10:08:22 AM
Targacept, Inc. (TRGT) To Report Third Quarter 2014 Financial Results On November 5, 2014 10/29/2014 9:14:43 AM
12345678910...
//-->